Emgality 120MG/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBAEW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,678
Award facts
- Contract value 100% obligated
- $13,677.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,677.85 delivery order to AmerisourceBergen Drug Corp on May 21, 2026, for Emgality 120mg/ml under its Pharmaceutical Prime Vendor Global Program Generation V single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency, valued at $4.999 million through December 2036.
The order is firm fixed price with no set-aside. Place of performance is Conshohocken, PA. Ultimate completion date is May 22, 2026.
Quick answers
Who was awarded contract SPE2DR26FBAEW?
SPE2DR26FBAEW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 21, 2026.
How much is contract SPE2DR26FBAEW worth?
The government has obligated $13,678 on SPE2DR26FBAEW.
Is contract SPE2DR26FBAEW an order under another contract?
Yes. SPE2DR26FBAEW is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBAEW competed?
The extent of competition for SPE2DR26FBAEW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award